Nipro

CompanyJapan

Nipro develops one asset. Mostly cell therapy; based in Japan.

1
Asset
Furthest stage
Not known
0
Trials
1
Signal

Pipeline

1
  • Stemirac

    Autologous bone marrow-derived mesenchymal stem cells promote tissue repair following spinal cord injury.

    Stage not known, Cell therapy

Full company profiles: pipeline, trials, funding and people.

See Pro

In the full profile

  • Signals1

Intelligence